Objectives: To determine the utility of immunohistochemistry (IHC) for the diagnosis of viral infections in surgical pathology specimens lacking characteristic viral cytopathic effects.
Viruses are a highly diverse group of organisms that are responsible for considerable morbidity and mortality. 1 Due to overlap in symptoms, a variety of factors are considered to determine whether the diagnosis of a specific viral infection is necessary to manage the care of a particular patient, including the severity of symptoms, availability of specific treatments, and the risk of transmission to other individuals. Once a viral etiology enters the clinical differential diagnosis, a combination of tests, including serology, polymerase chain reaction (PCR), culture, and biopsy, can be used to establish the diagnosis. Characteristic cytologic changes accompany many viral infections (viral cytopathic effect [VCPE] ), allowing for definitive diagnosis by H&E alone in most cases. VCPEs are most often associated with DNA viruses and include increased cell size, multinucleation, and the presence of nuclear or cytoplasmic inclusion bodies (aggregates of viral proteins that appear glassy or smudged). 2 Additional histologic findings, including the quantity of cells involved and patterns of inflammation, may help determine whether the virus detected is responsible for the patient's symptoms or is more likely to be an incidental finding. Commonly encountered viruses in surgical pathology include cytomegalovirus (CMV), herpes simplex virus 1 and 2 (HSV-1 and HSV-2), varicella zoster virus (VZV), adenovirus, and polyomaviruses (ie, BK and JC). These viruses are ubiquitous in the population and can cause severe or sometimes fatal illness through primary infection or reactivation of latent virus in immunosuppressed patients. CMV, characterized by very large cells, basophilic "owl's eye" nuclei, and small granular cytoplasmic inclusions, can cause a mononucleosis-like syndrome, severe congenital infections, and organ-specific or disseminated disease in immunosuppressed individuals, particularly those with human immunodeficiency virus infection and low CD4 counts, and recipients of bone marrow and solid organ transplantations.
3-5 HSV-1 and HSV-2 produce large, often multinucleated cells with prominent glassy viral inclusions and cause oral and genital lesions, rare primary fulminant hepatitis and encephalitis, and reactivation with dissemination in the immunocompromised population. 6, 7 VZV has VCPE identical to HSV-1 and HSV-2 and causes varicella (chickenpox) and herpes zoster (shingles) and can disseminate in immunocompromised patients, resulting in severe central nervous system, pulmonary, and hepatic symptoms. 8, 9 Adenovirus infection produces glassy to smudged nuclei in a variety of cell types, resulting in a range of mild to severe and life-threatening infections, particularly in the lungs and gastrointestinal tract. 10 Polyomavirus, characterized by enlarged basophilic glassy nuclei in tubular epithelial cells and oligodendrocytes, can cause severe nephropathy and progressive multifocal leukoencephalopathy, respectively. 11, 12 There are different drugs available for treating each of these viruses or other treatment options, such as decrease of transplantassociated immunosuppression. Immunohistochemistry (IHC) is a powerful ancillary test in surgical pathology. While additional diagnostic information can be gained, IHC adds to the overall cost (an estimated $100 per IHC slide) and turnaround time; reduction of unnecessary stains has been proposed as an area for potential significant cost savings. 13, 14 In viral infections, IHC is often used for confirmation of H&E findings or when there is clinical suspicion but no VCPE is identified. The utility of IHC in confirming active infections and, more important, in biopsy specimens from patients in whom there is clinical suspicion of viral infection but no VCPE is unknown. In this study, we evaluated the utility of IHC for identifying viral infections and the impact of IHC on patient care in this context.
Materials and Methods
After institutional review board approval, surgical pathology cases at Brigham and Women's Hospital (Boston, MA) over a 5-year period were electronically reviewed for the use of IHC to detect CMV, HSV-1 and HSV-2, VZV, adenovirus, or polyomavirus (ie, BK or JC). IHC for parvovirus and hepatitis B virus was excluded due to insufficient numbers of cases for analysis. Human herpes virus 8 IHC and in situ hybridization for Epstein-Barr virus-encoded RNA were excluded due to their established role in the diagnosis of malignancy. Autopsy, cytology, and consult cases were also excluded from this study due to limited numbers of cases, to minimize variations in the quality of histology, and to ensure availability of material for review. H&E slides from all cases reported as positive by IHC were reevaluated for VCPE by three pathologists (I.H.S., J.L.H., and A.C.L.) blinded to the IHC results. The number of cells with VCPE on H&E was grouped as negative (0), suspicious (?), single (1), rare (2-5), or abundant (>5). The number of cells with positive staining on IHC was grouped as negative (0), single (1), rare (2-5), or abundant (>5). Electronic medical records, including associated culture results and clinical notes, were reviewed to determine whether there was a change in treatment as a result of a positive IHC stain in cases without definitive VCPE.
Results
In total, 1,636 viral IHC stains were ordered on 1,099 specimens from 957 accessions (independent cases). Altogether, 101 (75.4%) of 134 cases contained readily identifiable VCPE on H&E slides Image 1 and Table 2 . Specimens lacking definitive CMV VCPE, categorized as negative or suspicious on H&E, included 15 (30.6%) of 49 gastrointestinal specimens (11 colon/rectum, two small intestine, one stomach, one esophagus), one placenta specimen, two lung specimens, and one buccal mucosa specimen In all cases of CMV, negative or suspicious VCPE H&E findings were associated with only rare IHC-positive cells. Four cases (seven total specimens) from patients with ulcerative colitis and seven cases (eight total specimens) from patients with hematologic malignancies (three chronic lymphocytic leukemia, two acute myeloid leukemia, one acute lymphoblastic leukemia, and one multiple myeloma) resulted in either no CMV treatment or continued treatment/ prophylaxis for an established CMV infection. The remaining cases-one placenta from a known case of congenital CMV infection, one face transplant biopsy specimen from a patient with known foscarnet-resistant CMV, one congestive heart failure exacerbation, and one lung transplant patient-also resulted in no changes in CMV-associated therapy. Five of the 15 cases had concurrent cultures, all of which were negative, and two patients received no treatment while three continued to receive their current antiviral therapy. In cases of negative HSV-1 and HSV-2 VCPE, three women's and perinatal specimens (two cervix, one vagina), one skin biopsy specimen, and one brain clot contained abundant IHC-positive cells. In all cases, a prior diagnosis or strong clinical suspicion existed, and no significant changes in therapy occurred. Two of the six cases had associated cultures, one positive and one negative, both of which received treatment. Similarly, two skin biopsy specimens, a brain biopsy specimen, and a brain artery biopsy specimen had prior VZV diagnoses; three of the four had virus detected by PCR in concurrent specimens and resulted in no changes in therapy. Finally, polyomavirus (BK virus) was detected in four biopsy specimens of kidney transplants (one with no available follow-up) and one bladder biopsy specimen in a patient with acute myeloid leukemia, three with BK virus detected by PCR in blood or urine, which resulted in no changes in treatment. Taken together, no cases without definitive VCPE that had positive staining cells on IHC (0/33 [0%]) resulted in a significant change in clinical care Table 3 .
Discussion
IHC is the most frequently used ancillary test in surgical pathology. Although its main use relates to the establishment of cell lineage for the diagnosis of malignancy, the use of IHC in the investigation of infection has been increasing. In the case of many viral infections, the presence of VCPE 
Negative (0) The sensitivity of IHC cannot be determined in this retrospective study, since few surgical specimens had concurrent tissue sent for viral culture, the gold standard for diagnosis. The sensitivity of VCPE compared with IHC in this study is 75.4% (101/134 specimens) with a specificity of 98.1% (101/103). The true sensitivity is likely lower, due to the existence of cases that did not have IHC but may have had rare positive cells. However, while IHC detects more cases with virally infected cells than H&E alone, the clinical significance of these diagnoses is unclear. True false positives are extremely uncommon, and most cases with positive VCPE and negative IHC result from exhaustion of the diagnostic tissue. Due to a lack of guidelines, considerable variability exists among pathologists in the utilization of IHC for the diagnosis of viral infections. Experience of the pathologist heavily influences whether IHC is ordered either to confirm suspicious VCPE on H&E or to screen cases that are negative for definite VCPE but have otherwise suspicious histology or clinical history. A strength of this study is the large number of cases initially read by dozens of pathologists, allowing for a more accurate picture of the average practice habits. However, the indications for specific viral IHC are poorly documented in most cases, obfuscating the original intent and subsequent analysis.
CMV can be both a cause of disease and an incidental finding of latent or reactivated virus in a site of local immunosuppression. Active infection is often associated with readily identifiable VCPE on H&E, allowing for unequivocal diagnosis. The presence of single or scattered IHC-positive cells requires correlation with other laboratory tests, including plasma viral loads and culture. The most commonly encountered specimens with a positive IHC stain in the absence of diagnostic VCPE are gastrointestinal biopsy specimens with CMV in the setting of inflammatory bowel disease or organ transplantation. CMV is associated with a worse prognosis in patients with inflammatory bowel disease and transplant recipients, and timely diagnosis and treatment of CMV with antivirals have been shown to improve outcomes. 3, 5 Other studies have
shown similar results where H&E has had lower sensitivity for CMV compared with IHC or in situ hybridization. 15 PCR of formalin-fixed, paraffin-embedded tissue has been proposed as an alternative, possibly more sensitive assay compared with H&E or IHC. The clinical significance of samples only positive by PCR is unclear. 16, 17 Another study suggested that in patients whose biopsy specimens showed even isolated IHCpositive cells (8/30 cases), five of eight had worsening symptoms that improved with antiviral therapy. 18 In this study, none of the cases with a positive CMV IHC with negative VCPE resulted in a change in treatment, arguing against the usefulness of IHC in this scenario.
HSV-1/HSV-2 and VZV produce morphologically identical VCPE characterized by multinucleated cells with glassy viral intranuclear inclusions and chromatin margination. 19, 20 While these viruses could theoretically occur anywhere in the body, the most likely site where they may be confused is the skin, as evidenced by the 96 (82.8%) of 116 skin biopsy specimens in this study that were stained both for HSV-1/HSV-2 and VZV. In addition to having similar VCPE, HSV-1/HSV-2 and VZV are also treated with the same firstline antiviral agent, acyclovir, minimizing the utility of distinction from a treatment perspective. In contrast to CMV, negative VCPE for VZV resulted in two cases with abundant (rather than single or rare) cells positive by IHC, both of which involved hair follicle cells. This likely represents an early stage of infection, where the virus has not yet spread to the epidermis. 21 However, the patients either remained on existing treatment or were given no treatment, suggesting that the lack of a diagnosis by IHC would have had a minimal impact on patient care. While no changes in treatment occurred, confirmation of VZV and HSV-1/HSV-2 infections of the brain by IHC may be useful to rule out other treatable etiologies. Adenovirus infections can cause severe respiratory or gastrointestinal disease in the immunosuppressed population, including hematopoietic stem cell and solid organ transplant recipients. 22 While distinct VCPE can be observed, they are more subtle than for CMV, HSV-1/HSV-2, and VZV and may be difficult to distinguish from reactive cells. Consequently, there appears to be a lower threshold for ordering adenovirus IHC compared with the other viruses in this study, as illustrated by only three (1.4%) of 210 positive cases. All three cases contained observable VCPE on H&E; thus, no additional cases were identified, and no changes in treatment would have occurred had adenovirus IHC not been tested. Polyomaviruses, including JC and BK, are ubiquitous and cause significant disease in immunosuppressed patients. 11, 23 This commonly manifests as BK nephropathy in kidney transplant patients, which requires modulation of immunosuppressive drug regimens to avoid loss of the graft. 12 While a tissue diagnosis can be helpful, less invasive testing, including quantitative viral loads and examination of cytology samples for polyomavirus-infected "decoy" cells, may be sufficient. 24, 25 Of the four kidney cases in this study with suspicious but not definitive VCPE, only rare cells were detected by IHC, resulting in no changes in therapy. In summary, this study suggests that the use of IHC for the diagnosis of viral infections in surgical specimens is unnecessary in most cases. Most IHC stains ordered were negative, and none of the 33 (2.0%) of 1,636 stains that were positive without unequivocal VCPE on H&E resulted in significant changes in patient management. In cases with strong clinical suspicion and negative VCPE, IHC may still play a role in confirming an actionable diagnosis, which requires clear communication between the clinical team and the pathologist. In these cases in particular, the pathologist can play a key role in the clinical care team by correlating clinical, laboratory, and histologic findings. In cases without suspicious VCPE or a compelling history, routine IHC screening for viral infections is not recommended due to the low yield and questionable clinical significance of rare positive cells. For such cases, a descriptive diagnosis such as "cells with viral cytopathic effects consistent with cytomegalovirus" or "changes suggestive of herpes virus infection" may suffice. We would like to emphasize that we are not recommending against the use of IHC for detection of viruses in surgical pathology specimens but rather advocating for judicious use of it.
